A tool used to assess psychosocial variables in potential solid organ transplant recipients may also provide predictive benefits for patients under consideration for hematopoietic cell transplantation.
Mutation Clonal Burden and Transplantation Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Although studies have established the prognostic significance of specific genetic mutations in AML and MDS, the role of mutations as prognostic factors of outcomes after HCT is still unclear.
Personalized Survivorship Care Plans Reduce Distress, Improve QOL in HCT Survivors
The use of survivorship care plans derived from registry data and personalized to patient-specific exposures is associated with improved mental health domain of quality of life and reduced distress.